We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 29, 2020

Real-World Adverse Events Associated With CAR T-Cell Therapy in Adults ≥65 Years

Journal of Geriatric Oncology


Additional Info

Journal of Geriatric Oncology
Real-World Adverse Events Associated With CAR T-Cell Therapy Among Adults Age ≥65 Years
J Geriatr Oncol 2020 Aug 11;[EPub Ahead of Print], ME Zettler, BA Feinberg, EG Phillips Jr, AJ Klink, S Mehta, A Gajra

Further Reading